All Type of News
2018 National Health Insurance Contribution Rate decided to raise by 2.04%
The Ministry of Health and Welfare(MOHW) held the 14th Health Insurance Policy Deliberation Committee on the 29th and decided to raise the 2018 Health Insurance Contribution Rate’ by 2.04%.
It will adjust the contrib...
MOHW’s KRW 141.9 billion and KRW 59.8 billion increases for health industry and R&D next year
The Ministry of Health and Welfare(MOHW) made up a KRW 141.9 billion budget for the healthcare and pharmaceutical industries for the next year, increased by KRW 59.8 billion compared to this year.
A new budget was al...
Will Lilly Korea’s ‘Lartruvo’ be a new alternative for treatment of soft tissue sarcoma
‘Soft tissue sarcoma’ is malignant cells that develop in connective tissues in human body. The disease usually has no symptoms until a tumor gets bigger, but patients visit a hospital due to pains caused by pressure t...
Hanmi Pharm jumps into an approx. KRW 140 billion market of chronic hepatitis B treaments
Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) will jump into the market of chronic hepatitis B treatments containing tenofovir, which forms a market of approximately KRW 140 billion a year.
After acquiring commercial...
ETC/OTC ratio stays at 83:17 for 5 years
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) published the ‘2016 Manufacturing Performance Table for Medicines’ on the 28th. Divided into 2 volumes and a reference section, t...
‘Agents for arteriosclerosis’ manufactured the most, 3 therapeutic categories manufactured for more than KRW 1 trillion
Agents for arteriosclerosis were reportedly manufactured the most last year.
The ‘Medicines Outputs by Therapeutic Category’ totaled by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association on therapeutic...
Quinvaxem Inj manufactured the most last year while Dong-A ST made the most products in top 50
A pharmaceutical product manufactured the most last year was reportedly ‘Quinvaxem Inj.’
The ‘Top 50 Finished Medicine Outputs by Product(2016)’ totaled by the Korea Pharmaceutical and Bio-Pharma Manufacturers Associ...
MOHW fires a flare to localize Korean medical devices in China
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) has started to bear fruit in the ongoing business of expanding and localizing medical devices in China.
The MOHW and the Korea Medical Devices Industr...
Pharmaceutical distribution association considers accusing monopolistic distribution companies invested by medical institutes
The Korea Pharmaceutical Distribution Association(Chairman Chi-Yup Hwang) is known to aggressively consider accusing pharmaceutical distribution companies invested by medical devices to the Fair Trade Commission for m...
KOSDAQ listed pharmas outnumbers in operating profit increase rate and operating profit/sales ratio
The KOSDAQ listed pharmaceutical companies’ operating profit in/decrease rate was 4 times higher than the one of KOSPI listed pharmaceutical companies in the 1st half of the year compared to the same period of the las...
